Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: The Feasibility of Florbetapir Quantitation [Phase 4]
A Phase 4 trial update assessing the feasibility of quantifying florbetapir for PET imaging in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Olfactory Neuroepithelial Tissue of Alzheimer Disease
A completed clinical trial investigating olfactory neuroepithelium in individuals with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease [NA]
Clinical trial update indicating the completion of NCT01126099 evaluating prazosin for disruptive agitation in Alzheimer's disease. Results …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Sound Estimation and Accuracy Task [NA]
The Sound Estimation and Accuracy Task trial (NCT02271685) sponsored by Carnegie Mellon University has completed and involves Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles [NA]
This clinical trial update investigates brain changes associated with rivastigmine in Alzheimer's disease, stratified by butyrylcholinestera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Project ACT: Advancing Caregiving Techniques [Phase 3]
Phase 3 clinical trial evaluating Project ACT, a caregiving techniques program for Alzheimer's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease [Phase 2]
Phase 2 long-term follow-up study in Alzheimer's disease completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20) [Phase 3]
A Phase 3 randomized, double-blind study comparing two titration methods of the rivastigmine transdermal patch in Alzheimer's disease patien…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating a dietary supplement version of Anatabloc for Alzheimer's disease has been terminated. The trial was sponsored by…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Online Caregiver Psychoeducation and Support for Alzheimer's [Phase 2, Phase 3]
This document reports the completion and results posting of a Phase 2/3 clinical trial sponsored by the US Department of Veterans Affairs ev…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease [NA]
This update indicates a completed clinical trial evaluating sensory support care for elderly patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
Completed clinical trial evaluating Cerefolin and CerefolinNAC on biomarker measurements in people with mild cognitive impairment and Alzhei…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment [Phase 1]
A Phase 1 pharmacokinetics and pharmacodynamics study of POSIPHEN in subjects with amnestic mild cognitive impairment and Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development [Phase 1]
An early-phase clinical trial evaluating cognitive properties of new drug candidates for Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Pain Management and Behavioral Outcomes in Patients With Dementia [Phase 2]
Phase 2 clinical trial update from the US Department of Veterans Affairs assessing pain management and behavioral outcomes in dementia patie…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Supporting Caregivers of Persons With Dementia: A Pilot Study [Phase 2, Phase 3]
A completed Phase 2/Phase 3 pilot study evaluating a caregiver-support intervention for individuals with Alzheimer's disease and other forms…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Testing the Effectiveness of Telephone Support for Dementia Caregivers [NA]
The clinical trial evaluating the effectiveness of telephone support for dementia caregivers has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Nurse Managed Clinic for Dementia Patients and Family Caregivers
A completed clinical trial evaluating a nurse-managed clinic model for dementia patients and their family caregivers.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Telehealth Education Program for Caregivers of Veterans With Dementia [NA]
This completed clinical trial evaluated a telehealth education program for caregivers of veterans with dementia, including Alzheimer's disea…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Effect of Activity on Sleep of Cognitively-Impaired Veterans [NA]
Completed clinical trial assessing the effect of activity on sleep in cognitively impaired veterans; the update notes completion but does no…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Raloxifene for Women With Alzheimer's Disease [Phase 2]
Results from a Phase 2 trial of raloxifene in women with Alzheimer's disease have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Phase 3 IGIV, 10% in Alzheimer´s Disease [Phase 3]
Phase 3 trial of intravenous immunoglobulin (IGIV) in Alzheimer’s disease was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology [Phase 3]
Phase III trial evaluating Florbetaben PET imaging for detecting cerebral beta-amyloid compared with histopathology has completed, with resu…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects. [Phase 1]
This Phase I trial assessed safety, tolerability, and pharmacokinetics of a donepezil patch in healthy male subjects using a randomized, sin…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients [Phase 1]
A Phase 1 single- and multiple-dose study assessing the safety and pharmacokinetics of SAR228810 in Alzheimer's disease patients has complet…